Cost-utility of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations: a randomized, controlled trial
Rheumatology International · 05.06.2026 · 46 (6)
DOI: 10.1007/s00296-026-06160-x ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Rheumatology International, online erschienen am 05.06.2026. Verfasst von Maria A T van Wissen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Rehabilitation and Physical Therapy, Leiden University Medical Center, Albinusdreef 2, P.O.Box 9600, Leiden, 2300 RC, The…. Hauptthemen laut MEDLINE: Exercise Therapy, Axial Spondyloarthritis, Health Care Costs. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw NL, Ministry of Health, Welfare and Sport (Ministerie van Volksgezondheid, Welzijn en Sport), Koninklijk Nederlands Genootschap voor Fysiotherapie.
Abstract (Originalsprache)
To evaluate the cost-utility of long-term, personalized, exercise therapy as compared to usual care in people with axial spondyloarthritis (axSpA) and severe functional limitations. A comprehensive economic evaluation was conducted from a societal perspective alongside a randomized controlled trial involving 214 participants (110 individuals assigned to the intervention group and 104 to the usual care group), with a one-year follow-up. Cost assessments encompassed both medical and non-medical costs recorded by participants and healthcare providers. Quality Adjusted Life Years (QALYs) were calculated using the EuroQol-5 Dimensions -5 Levels (EQ-5D-5L) and EuroQol Visual Analogue Scale (EQ-VAS). Costs and QALY differences were analysed using standard unequal variance t-tests according to the intention-to-treat principle and cost-effectiveness acceptability curves. In the intervention group, 93% of the participants used the intervention with an average of 41 (standard deviation, SD 15) sessions, with the mean direct costs of the intervention being €1515 (SD 724) per participant. The total mean physiotherapy costs were €1967 (SD 801) in the intervention and €514 (SD 792) in the control group, respectively. Although not statistically significant, the total societal costs also favoured the usual care group after 52-weeks, showing a difference of €657 (95% confidence interval (CI) €-3748 to €5060). QALYs were slightly and non-significantly favouring the intervention group, with a difference of 0.02 based on the EQ-5D-5 L (95% CI − 0.04 to 0.09) and 0.00 according to the EQ-VAS (95% CI -0.04 to 0.04). At a willingness-to-pay threshold of €50,000 per QALY, the intervention had a 57% likelihood of being considered the cost-effective strategy. The higher intervention costs of the long-term exercise therapy intervention were negated by savings on other healthcare and non-healthcare costs and by improved QALYs. As a result, we found no clear economic preference: long-term exercise therapy need not be withheld for economic reasons from people with axSpA and severe functional limitations. Registration number Netherlands Trial Register NL-OMON52399, included in the International Clinical Trial Registry Platform (ICTRP) (https://trialsearch.who.int/Trial2.aspx? TrialID=NL-OMON52399).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics, Rehabilitation and Physical Therapy, Leiden University Medical Center, Albinusdreef 2, P.O.Box 9600, Leiden, 2300 RC, The Netherlands.
- Institute of Allied Health Professions, HU University of Applied Sciences, Utrecht, Netherlands.
- Department of Research, Sint Maartenskliniek, Nijmegen, The Netherlands.
- Department of Rheumatology, Radboud UMC, Nijmegen, The Netherlands.
- Department of Orthopaedics, Rehabilitation and Physical Therapy, Leiden University Medical Center, Albinusdreef 2, P.O.Box 9600, Leiden, 2300 RC, The Netherlands. t.p.m.vliet_vlieland@lumc.nl.
- Center for Rehabilitation and Rheumatology, Reade, Amsterdam, The Netherlands.
Förderung
- ZonMw NL
- Ministry of Health, Welfare and Sport (Ministerie van Volksgezondheid, Welzijn en Sport)
- Koninklijk Nederlands Genootschap voor Fysiotherapie
- Dutch Arthritis Association
Zitieren
APA
van Wissen, M. A. T., van Weely, S. F. E., van den Ende, C. H. M., Vliet Vlieland, T. P. M., Teuwen, M. M. H., Peter, W. F., Mahler, E. A. M., van Schaardenburg, D., van Gaalen, F., Spoorenberg, J. P. L., van Tubergen, A. M., Gademan, M. G. J., & van den Hout, W. B. (2026). Cost-utility of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations: a randomized, controlled trial. Rheumatology International, 46(6). https://doi.org/10.1007/s00296-026-06160-x
Vancouver
van Wissen MAT, van Weely SFE, van den Ende CHM, Vliet Vlieland TPM, Teuwen MMH, Peter WF, et al. Cost-utility of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations: a randomized, controlled trial. Rheumatology International. 2026;46(6). doi:10.1007/s00296-026-06160-x
BibTeX
@article{vanWissen2026,
author = {van Wissen, Maria A T and van Weely, Salima F E and van den Ende, Cornelia H M and Vliet Vlieland, Theodora P M and Teuwen, Max M H and Peter, Wilfred F and Mahler, Eline A M and van Schaardenburg, Dirkjan and van Gaalen, Floris and Spoorenberg, Johanna P L and van Tubergen, Astrid M and Gademan, Maaike G J and van den Hout, Wilbert B},
title = {Cost-utility of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations: a randomized, controlled trial},
journal = {Rheumatology International},
year = {2026},
volume = {46},
number = {6},
doi = {10.1007/s00296-026-06160-x}
}
EUVIMED